Transformation of colitis and colorectal cancer: a tale of gut microbiota

References

• Abdulla MH, Agarwal D, Singh JK, Traiki TB, Pandey MK, Ahmad R, Srivastava SK. 2021. Association of the microbiome with colorectal cancer development (Review). Int J Oncol. 58(5):17. doi: 10.3892/ijo.2021.5197.
   PubMed Web of Science ®Google Scholar
• Abreu MT. 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 10(2):131–144. doi: 10.1038/nri2707.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Mullish BH, Kelly C, Fischer M. 2019. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet. 394(10196):420–431. doi: 10.1016/S0140-6736(19)31266-8.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. 2015. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 13(2):322–329.e1. doi: 10.1016/j.cgh.2014.07.018.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 338(6103):120–123. doi: 10.1126/science.1224820.
   PubMed Web of Science ®Google Scholar
• Baker AM, Cross W, Curtius K, Al Bakir I, Choi CR, Davis HL, Temko D, Biswas S, Martinez P, Williams MJ, et al. 2019. Evolutionary history of human colitis-associated colorectal cancer. Gut. 68(6):985–995. doi: 10.1136/gutjnl-2018-316191.
   PubMed Web of Science ®Google Scholar
• Benninghoff AD, Hintze KJ, Monsanto SP, Rodriguez DM, Hunter AH, Phatak S, Pestka JJ, Wettere AJV, Ward RE. 2020. Consumption of the total Western diet promotes colitis and inflammation-associated colorectal cancer in mice. Nutrients. 12(2):544. doi: 10.3390/nu12020544.
   PubMed Web of Science ®Google Scholar
• Biancone L, Armuzzi A, Scribano ML, Castiglione F, D'Incà R, Orlando A, Papi C, Daperno M, Vecchi M, Riegler G, et al. 2020. Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study. Inflamm Bowel Dis. 26(3):450–459. doi: 10.1093/ibd/izz155.
   PubMed Web of Science ®Google Scholar
• Birch RJ, Burr N, Subramanian V, Tiernan JP, Hull MA, Finan P, Rose A, Rutter M, Valori R, Downing A, et al. 2022. Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study. Am J Gastroenterol. 117(11):1858–1870. doi: 10.14309/ajg.0000000000001941.
   PubMed Web of Science ®Google Scholar
• Brennan CA, Garrett WS. 2019. Fusobacterium nucleatum – symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 17(3):156–166. doi: 10.1038/s41579-018-0129-6.
   PubMed Web of Science ®Google Scholar
• Cai J, Sun L, Gonzalez FJ. 2022. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 30(3):289–300. doi: 10.1016/j.chom.2022.02.004.
   PubMed Web of Science ®Google Scholar
• Cao Y, Oh J, Xue M, Huh WJ, Wang J, Gonzalez-Hernandez JA, Rice TA, Martin AL, Song D, Crawford JM, et al. 2022. Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites. Science. 378(6618):eabm3233. doi: 10.1126/science.abm3233.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B, Shen C, Ma Y, Jiang S, Ma D, et al. 2021. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p. Gastroenterology. 161(5):1552–1566.e12. doi: 10.1053/j.gastro.2021.08.003.
   PubMed Web of Science ®Google Scholar
• Casasanta MA, Yoo CC, Udayasuryan B, Sanders BE, Umaña A, Zhang Y, Peng H, Duncan AJ, Wang Y, Li L, et al. 2020. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 13(641):1–30. doi: 10.1126/scisignal.aba9157.
   Web of Science ®Google Scholar
• Chen J, Pitmon E, Wang K. 2017. Microbiome, inflammation and colorectal cancer. Semin Immunol. 32:43–53. doi: 10.1016/j.smim.2017.09.006.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen YX. 2021. Microbiota-associated metabolites and related immunoregulation in colorectal cancer. Cancers. 13(16):4054. doi: 10.3390/cancers13164054.
   PubMed Web of Science ®Google Scholar
• Chiang MK, Hsiao PY, Liu YY, Tang HL, Chiou CS, Lu MC, Lai YC. 2021. Two ST11 Klebsiella pneumoniae strains exacerbate colorectal tumorigenesis in a colitis-associated mouse model. Gut Microbes. 13(1):1980348. doi: 10.1080/19490976.2021.1980348.
   PubMed Web of Science ®Google Scholar
• Chung Y, Ryu Y, An BC, Yoon YS, Choi O, Kim TY, Yoon J, Ahn JY, Park HJ, Kwon SK, et al. 2021. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome. 9(1):122. doi: 10.1186/s40168-021-01071-4.
   PubMed Web of Science ®Google Scholar
• Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, et al. 2019. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. J Am Med Assoc. 321(2):156–164. doi: 10.1001/jama.2018.20046.
   PubMed Web of Science ®Google Scholar
• Denk D, Greten FR. 2022. Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 8(11):901–914. doi: 10.1016/j.trecan.2022.07.002.
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. 2001. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 48(4):526–535. doi: 10.1136/gut.48.4.526.
   PubMed Web of Science ®Google Scholar
• Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. 2022. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 22(12):703–722. doi: 10.1038/s41568-022-00513-x.
   PubMed Web of Science ®Google Scholar
• Fong W, Li Q, Yu J. 2020. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 39(26):4925–4943. doi: 10.1038/s41388-020-1341-1.
   PubMed Web of Science ®Google Scholar
• Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, et al. 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 8(3):292–300. doi: 10.1016/j.chom.2010.08.004.
   PubMed Web of Science ®Google Scholar
• Garrett WS. 2019. The gut microbiota and colon cancer. Science. 364(6446):1133–1135. doi: 10.1126/science.aaw2367.
   PubMed Web of Science ®Google Scholar
• Gatsios A, Kim CS, Crawford JM. 2021. Escherichia coli small molecule metabolism at the host-microorganism interface. Nat Chem Biol. 17(10):1016–1026. doi: 10.1038/s41589-021-00807-5.
   PubMed Web of Science ®Google Scholar
• Gomes S, Baltazar F, Silva E, Preto A. 2022. Microbiota-derived short-chain fatty acids: new road in colorectal cancer therapy. Pharmaceutics. 14(11):2359. doi: 10.3390/pharmaceutics14112359.
   PubMed Web of Science ®Google Scholar
• Gomes SD, Oliveira CS, Azevedo-Silva J, Casanova MR, Barreto J, Pereira H, Chaves SR, Rodrigues LR, Casal M, Côrte-Real M, et al. 2020. The role of diet related short-chain fatty acids in colorectal cancer metabolism and survival: prevention and therapeutic implications. Curr Med Chem. 27(24):4087–4108. doi: 10.2174/0929867325666180530102050.
   PubMed Web of Science ®Google Scholar
• Górska A, Przystupski D, Niemczura MJ, Kulbacka J. 2019. Probiotic bacteria: a promising tool in cancer prevention and therapy. Curr Microbiol. 76(8):939–949. doi: 10.1007/s00284-019-01679-8.
   PubMed Web of Science ®Google Scholar
• Gröschel C, Prinz-Wohlgenannt M, Mesteri I, Karuthedom George S, Trawnicek L, Heiden D, Aggarwal A, Tennakoon S, Baumgartner M, Gasche C, et al. 2019. Switching to a healthy diet prevents the detrimental effects of Western diet in a colitis-associated colorectal cancer model. Nutrients. 12(1):45. doi: 10.3390/nu12010045.
   PubMed Web of Science ®Google Scholar
• Guo S, Peng Y, Lou Y, Cao L, Liu J, Lin N, Cai S, Kang Y, Zeng S, Yu L. 2022. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization. Pharmacol Res. 177:106101. doi: 10.1016/j.phrs.2022.106101.
   PubMed Web of Science ®Google Scholar
• Hirsch D, Hardt J, Sauer C, Heselmeyer-Hadded K, Witt SH, Kienle P, Ried T, Gaiser T. 2021. Molecular characterization of ulcerative colitis-associated colorectal carcinomas. Mod Pathol. 34(6):1153–1166. doi: 10.1038/s41379-020-00722-5.
   PubMed Web of Science ®Google Scholar
• Hofer U. 2022. Fusobacterium orchestrates oral biofilms. Nat Rev Microbiol. 20(10):576. doi: 10.1038/s41579-022-00787-w.
   Google Scholar
• Hou H, Chen D, Zhang K, Zhang W, Liu T, Wang S, Dai X, Wang B, Zhong W, Cao H. 2022. Gut microbiota-derived short-chain fatty acids and colorectal cancer: ready for clinical translation? Cancer Lett. 526:225–235. doi: 10.1016/j.canlet.2021.11.027.
   PubMed Web of Science ®Google Scholar
• Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, et al. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 336(6086):1314–1317. doi: 10.1126/science.1221789.
   PubMed Web of Science ®Google Scholar
• Irrazabal T, Thakur BK, Kang M, Malaise Y, Streutker C, Wong EOY, Copeland J, Gryfe R, Guttman DS, Navarre WW, et al. 2020. Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer. Nat Commun. 11(1):1802. doi: 10.1038/s41467-020-15549-6.
   PubMed Web of Science ®Google Scholar
• Jackson DN, Theiss AL. 2020. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes. 11(3):285–304. doi: 10.1080/19490976.2019.1592421.
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. 2018. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 15(2):111–128. doi: 10.1038/nrgastro.2017.119.
   PubMed Web of Science ®Google Scholar
• Kadosh E, Snir-Alkalay I, Venkatachalam A, May S, Lasry A, Elyada E, Zinger A, Shaham M, Vaalani G, Mernberger M, et al. 2020. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic. Nature. 586(7827):133–138. doi: 10.1038/s41586-020-2541-0.
   PubMed Web of Science ®Google Scholar
• Karpiński TM, Ożarowski M, Stasiewicz M. 2022. Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 86(Pt 3):420–430. doi: 10.1016/j.semcancer.2022.01.004.
   PubMedGoogle Scholar
• Khoruts A, Staley C, Sadowsky MJ. 2021. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 18(1):67–80. doi: 10.1038/s41575-020-0350-4.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Meyerson M, Garrett WS. 2013. Microbes and inflammation in colorectal cancer. Cancer Immunol Res. 1(3):150–157. doi: 10.1158/2326-6066.CIR-13-0101.
   PubMed Web of Science ®Google Scholar
• Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, et al. 2019. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 49(4):354–363. doi: 10.1111/apt.15116.
   PubMed Web of Science ®Google Scholar
• Lee MH. 2021. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun. 41(10):937–967. doi: 10.1002/cac2.12200.
   Web of Science ®Google Scholar
• Lee SY, Lee DY, Kang JH, Kim JH, Jeong JW, Kim HW, Oh DH, Yoon SH, Hur SJ. 2022. Relationship between gut microbiota and colorectal cancer: probiotics as a potential strategy for prevention. Food Res Int. 156:111327. doi: 10.1016/j.foodres.2022.111327.
   PubMed Web of Science ®Google Scholar
• Li C, Wang Y, Liu D, Wong CC, Coker OO, Zhang X, Liu C, Zhou Y, Liu Y, Kang W, et al. 2022. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis. Gut. 71(11):2253–2265. doi: 10.1136/gutjnl-2021-325851.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang R, Li J, Li J. 2022. The role of C-type lectin receptor signaling in the intestinal microbiota-inflammation-cancer axis. Front Immunol. 13:894445. doi: 10.3389/fimmu.2022.894445.
   PubMedGoogle Scholar
• Liang X, Li H, Tian G, Li S. 2014. Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep. 4(1):4985. doi: 10.1038/srep04985.
   PubMedGoogle Scholar
• Liu J, Wang Y, Heelan WJ, Chen Y, Li Z, Hu Q. 2022. Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases. Sci Adv. 8(45):eabp8798. doi: 10.1126/sciadv.abp8798.
   PubMed Web of Science ®Google Scholar
• Liu M, Xie W, Wan X, Deng T. 2020. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice. Int Immunopharmacol. 88:106862. doi: 10.1016/j.intimp.2020.106862.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 12(10):661–672. doi: 10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature. 489(7415):220–230. doi: 10.1038/nature11550.
   PubMed Web of Science ®Google Scholar
• Lukas M. 2010. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis. 28(4–5):619–624. doi: 10.1159/000320276.
   PubMed Web of Science ®Google Scholar
• Mäki-Nevala S, Ukwattage S, Olkinuora A, Almusa H, Ahtiainen M, Ristimäki A, Seppälä T, Lepistö A, Mecklin JP, Peltomäki P. 2021. Somatic mutation profiles as molecular classifiers of ulcerative colitis-associated colorectal cancer. Int J Cancer. 148(12):2997–3007. doi: 10.1002/ijc.33492.
   PubMed Web of Science ®Google Scholar
• Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al. 2016. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 65(12):1973–1980. doi: 10.1136/gutjnl-2015-310101.
   PubMed Web of Science ®Google Scholar
• Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC. 2015. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol. 50(2):167–179. doi: 10.1007/s00535-014-0963-x.
   PubMed Web of Science ®Google Scholar
• Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F. 2020. Risk of colorectal cancer in inflammatory bowel diseases. Semin Cancer Biol. 64:51–60. doi: 10.1016/j.semcancer.2019.05.001.
   PubMed Web of Science ®Google Scholar
• Nagao-Kitamoto H, Kitamoto S, Kamada N. 2022. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev. 41(2):301–316. doi: 10.1007/s10555-022-10028-4.
   PubMed Web of Science ®Google Scholar
• Olén O, Erichsen R, Sachs MC, Pedersen L, Halfvarson J, Askling J, Ekbom A, Sørensen HT, Ludvigsson JF. 2020. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 395(10218):123–131. doi: 10.1016/S0140-6736(19)32545-0.
   PubMed Web of Science ®Google Scholar
• Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. 2022. Targeting the gut and tumor microbiota in cancer. Nat Med. 28(4):690–703. doi: 10.1038/s41591-022-01779-2.
   PubMed Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, et al. 2020. Mutational signature in colorectal cancer caused by genotoxic pks + E. coli. Nature. 580(7802):269–273. doi: 10.1038/s41586-020-2080-8.
   PubMed Web of Science ®Google Scholar
• Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. 2021. Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int J Mol Sci. 22(21):11365. doi: 10.3390/ijms222111365.
   PubMed Web of Science ®Google Scholar
• Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C, et al. 2014. Colonic mucosa-associated diffusely adherent afaC + Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut. 63(5):761–770. doi: 10.1136/gutjnl-2013-304739.
   PubMed Web of Science ®Google Scholar
• Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. 2022. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 28(30):4053–4060. doi: 10.3748/wjg.v28.i30.4053.
   PubMed Web of Science ®Google Scholar
• Ray K. 2021. Yeast probiotics for the treatment of IBD. Nat Rev Gastroenterol Hepatol. 18(9):594. doi: 10.1038/s41575-021-00497-3.
   Google Scholar
• Ronan V, Yeasin R, Claud EC. 2021. Childhood development and the microbiome-the intestinal microbiota in maintenance of health and development of disease during childhood development. Gastroenterology. 160(2):495–506. doi: 10.1053/j.gastro.2020.08.065.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 14(2):195–206. doi: 10.1016/j.chom.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Saeed M, Shoaib A, Kandimalla R, Javed S, Almatroudi A, Gupta R, Aqil F. 2022. Microbe-based therapies for colorectal cancer: advantages and limitations. Semin Cancer Biol. 86(Pt 3):652–665. doi: 10.1016/j.semcancer.2021.05.018.
   PubMedGoogle Scholar
• Sakai K, De Velasco MA, Kura Y, Nishio K. 2021. Transcriptome profiling and metagenomic analysis help to elucidate interactions in an inflammation-associated cancer mouse model. Cancers. 13(15):3683. doi: 10.3390/cancers13153683.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Greten FR. 2021. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 21(10):653–667. doi: 10.1038/s41577-021-00534-x.
   PubMed Web of Science ®Google Scholar
• Shah SC, Itzkowitz SH. 2022. Colorectal cancer in inflam­matory bowel disease: mechanisms and management. Gastroenterology. 162(3):715–730.e3. doi: 10.1053/j.gastro.2021.10.035.
   PubMed Web of Science ®Google Scholar
• Shao TY, Ang WXG, Jiang TT, Huang FS, Andersen H, Kinder JM, Pham G, Burg AR, Ruff B, Gonzalez T, et al. 2019. Commensal Candida albicans positively calibrates systemic Th17 immunological responses. Cell Host Microbe. 25(3):404–417.e6. doi: 10.1016/j.chom.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. 2020. Colorectal cancer statistics, 2020. CA Cancer J Clin. 70(3):145–164. doi: 10.3322/caac.21601.
   PubMed Web of Science ®Google Scholar
• Silveira DSC, Veronez LC, Lopes-Júnior LC, Anatriello E, Brunaldi MO, Pereira-da-Silva G. 2020. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World J Gastroenterol. 26(43):6782–6794. doi: 10.3748/wjg.v26.i43.6782.
   PubMed Web of Science ®Google Scholar
• Stecher B, Denzler R, Maier L, Bernet F, Sanders MJ, Pickard DJ, Barthel M, Westendorf AM, Krogfelt KA, Walker AW, et al. 2012. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A. 109(4):1269–1274. doi: 10.1073/pnas.1113246109.
   PubMed Web of Science ®Google Scholar
• Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, Lynch T, Allen-Vercoe E. 2011. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 17(9):1971–1978. doi: 10.1002/ibd.21606.
   PubMed Web of Science ®Google Scholar
• Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, et al. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. 13(11):1299–1307. doi: 10.1038/nm1652.
   PubMed Web of Science ®Google Scholar
• Thiele Orberg E, Fan H, Tam AJ, Dejea CM, Destefano Shields CE, Wu S, Chung L, Finard BB, Wu X, Fathi P, et al. 2017. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol. 10(2):421–433. doi: 10.1038/mi.2016.53.
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. 2011. Intestinal inflammation and cancer. Gastroenterology. 140(6):1807–1816. doi: 10.1053/j.gastro.2011.01.057.
   PubMed Web of Science ®Google Scholar
• Walter L, Canup B, Pujada A, Bui TA, Arbasi B, Laroui H, Merlin D, Garg P. 2020. Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer. Cell Death Dis. 11(9):767. doi: 10.1038/s41419-020-02959-z.
   PubMed Web of Science ®Google Scholar
• Wang F, Song M, Lu X, Zhu X, Deng J. 2022. Gut microbes in gastrointestinal cancers. Semin Cancer Biol. 86(Pt 2):967–975. doi: 10.1016/j.semcancer.2021.03.037.
   PubMedGoogle Scholar
• Wang T, Fan C, Yao A, Xu X, Zheng G, You Y, Jiang C, Zhao X, Hou Y, Hung MC, et al. 2018. The adaptor protein CARD9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells. Immunity. 49(3):504–514.e4. doi: 10.1016/j.immuni.2018.08.018.
   PubMed Web of Science ®Google Scholar
• Wang T, Wang P, Ge W, Shi C, Xiao G, Wang X, Lü X. 2021. The probiotic Companilactobacillus crustorum MN047 alleviates colitis-associated tumorigenesis via modulating the intestinal microenvironment. Food Funct. 12(22):11331–11342. doi: 10.1039/d1fo01531a.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang L, Wang P, Liu Y, Wang G, Shan Y, Yi Y, Zhou Y, Liu B, Wang X, et al. 2022. Lactobacillus coryniformis MXJ32 administration ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated colorectal cancer via reshaping intestinal microenvironment and alleviating inflammatory response. Eur J Nutr. 61(1):85–99. doi: 10.1007/s00394-021-02627-8.
   PubMed Web of Science ®Google Scholar
• Wang T, Zheng J, Dong S, Ismael M, Shan Y, Wang X, Lü X. 2022. Lacticaseibacillus rhamnosus LS8 ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated tumorigenesis in mice via regulating gut microbiota and inhibiting inflammation. Probiotics Antimicrob Proteins. 14(5):947–959. doi: 10.1007/s12602-022-09967-9.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang Y, Huycke MM. 2017. Microbiome-driven carcinogenesis in colorectal cancer: models and mechanisms. Free Radic Biol Med. 105:3–15. doi: 10.1016/j.freeradbiomed.2016.10.504.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li H. 2022. Gut microbiota modulation: a tool for the management of colorectal cancer. J Transl Med. 20(1):178. doi: 10.1186/s12967-022-03378-8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ren Y, Huang Y, Yu X, Yang Y, Wang D, Shi L, Tao K, Wang G, Wu K. 2021. Fungal dysbiosis of the gut microbiota is associated with colorectal cancer in Chinese patients. Am J Transl Res. 13:11287–11301.
   PubMed Web of Science ®Google Scholar
• Wijnands AM, de Jong ME, Lutgens MWMD, Hoentjen F, Elias SG, Oldenburg B. 2021. Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis. Gastroenterology. 160(5):1584–1598. doi: 10.1053/j.gastro.2020.12.036.
   PubMed Web of Science ®Google Scholar
• Wijnands AM, Mahmoud R, Lutgens MWMD, Oldenburg B. 2021. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: current practice and future perspectives. Eur J Intern Med. 93:35–41. doi: 10.1016/j.ejim.2021.08.010.
   PubMed Web of Science ®Google Scholar
• Wilson MR, Jiang Y, Villalta PW, Stornetta A, Boudreau PD, Carrá A, Brennan CA, Chun E, Ngo L, Samson LD, et al. 2019. The human gut bacterial genotoxin colibactin alkylates DNA. Science. 363(6428):eaar7785. doi: 10.1126/science.aar7785.
   PubMed Web of Science ®Google Scholar
• Wong NA, Herbst H, Herrmann K, Kirchner T, Krajewski AS, Moorghen M, Niedobitek F, Rooney N, Shepherd NA, Niedobitek G. 2003. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. J Pathol. 201(2):312–318. doi: 10.1002/path.1442.
   PubMed Web of Science ®Google Scholar
• Wozniak H, Beckmann TS, Fröhlich L, Soccorsi T, Le Terrier C, de Watteville A, Schrenzel J, Heidegger CP. 2022. The central and biodynamic role of gut microbiota in critically ill patients. Crit Care. 26(1):250. doi: 10.1186/s13054-022-04127-5.
   PubMedGoogle Scholar
• Wu Y, Jha R, Li A, Liu H, Zhang Z, Zhang C, Zhai Q, Zhang J. 2022. Probiotics (Lactobacillus plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related gene expression, gut microbiota, and metabolic pathways in mice. Microbiol Spectr. 10(6):e0165122. doi: 10.1128/spectrum.01651-22.
   PubMed Web of Science ®Google Scholar
• Xu J, Xu J, Shi T, Zhang Y, Chen F, Yang C, Guo X, Liu G, Shao D, Leong KW, et al. 2023. Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome. Adv Mater. 35:e2207890.
   PubMed Web of Science ®Google Scholar
• Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, Coker OO, Lau HCH, Chan AWH, Sung JJY, et al. 2022. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology. 162(1):135–149.e2. doi: 10.1053/j.gastro.2021.08.041.
   PubMed Web of Science ®Google Scholar
• Yang J, Yang H. 2023. Recent development in Se-enriched yeast, lactic acid bacteria and bifidobacteria. Crit Rev Food Sci Nutr. 63(3):411–425. doi: 10.1080/10408398.2021.1948818.
   PubMed Web of Science ®Google Scholar
• Yang J, Yu J. 2018. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell. 9(5):474–487. doi: 10.1007/s13238-018-0543-6.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gharaibeh RZ, Newsome RC, Jobin C. 2020. Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer. Nat Cancer. 1(7):723–734. doi: 10.1038/s43018-020-0078-7.
   PubMedGoogle Scholar
• Yu LC. 2018. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci. 25(1):79. doi: 10.1186/s12929-018-0483-8.
   PubMedGoogle Scholar
• Zhang H, Zhang M, Chen X, Guo M, Zhou R, Lv H, Li Y, Tan B, Li J, Xu H, et al. 2022. Risk of malignancy in patients with inflammatory bowel disease: a population-based cohort study from China. Int J Cancer. 150(11):1770–1778. doi: 10.1002/ijc.33932.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Shen ZF, Wu BS, Xu CB, He ZQ, Chen T, Shang HT, Xie CF, Huang SY, Chen YG, et al. 2019. Risk of colorectal cancer in ulcerative colitis patients: a systematic review and meta-analysis. Gastroenterol Res Pract. 2019:5363261–5363211. doi: 10.1155/2019/5363261.
   PubMed Web of Science ®Google Scholar
• Zhu W, Miyata N, Winter MG, Arenales A, Hughes ER, Spiga L, Kim J, Sifuentes-Dominguez L, Starokadomskyy P, Gopal P, et al. 2019. Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J Exp Med. 216(10):2378–2393. doi: 10.1084/jem.20181939.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shi T, Lu X, Xu Z, Qu J, Zhang Z, Shi G, Shen S, Hou Y, Chen Y, et al. 2021. Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22. Embo J. 40:e105320.
   PubMed Web of Science ®Google Scholar